Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
305 Leser
Artikel bewerten:
(1)

Next Frontier Brands' Subsidiary Treehouse Biotech Submits Novel Foods Application to the U.K. Food Standards Agency

Positions Treehouse Biotech to Become Validated Supplier of cGMP-Quality Hemp-Derived Cannabidiol (CBD) to the U.K. Food and Beverage Industries

BOULDER, Colo., Feb. 24, 2021 /PRNewswire/ -- Next Frontier Brands, a leading fast-moving consumer goods (FMCG) company, today announced the submission of a Novel Foods Application to the Food Standards Agency (FSA) in the United Kingdom (U.K.). The application, which was submitted by Next Frontier Brands' subsidiary Treehouse Biotech, is the company's latest move to capture the growing market for hemp-derived CBD-infused foods and beverages in the U.K.

Next Frontier Brands

"The submission of this Novel Foods Application supports our goal of establishing Treehouse Biotech as a global supplier of cGMP-quality cannabinoid ingredients and finished products to the food, beverage and wellness industries," said Shannon Soqui, Chief Executive Officer of Next Frontier Brands. "We have already partnered with several leading companies to develop innovative cannabinoid-based beverage and wellness products and look forward to fulfilling their needs for a U.K.-compliant supply chain."

"The U.K. novel food regulations require that all products containing CBD extracts and isolates must be sourced from an FSA-validated supplier," said Jake Black, Ph.D., Chief Scientific Officer of Treehouse Biotech. "After March 31, 2021, only products for which the FSA has a validated application will be allowed to remain on the market. This positions Treehouse Biotech to become the vendor of choice for U.K. brands seeking an FSA-validated cGMP-quality supplier of high-quality CBD ingredients."

Established in 2016, Treehouse Biotech is a leader in the research, development and production of hemp-derived cannabinoid ingredients, and purification and remediation technologies. The Treehouse Biotech team includes four Ph.D.s who are recognized leaders in cannabinoid research, development and commercial applications, three of whom specialize in organic chemistry and one of whom specializes in chemical engineering.

Treehouse Biotech has obtained cGMP (current good manufacturing practices) certifications for both food and dietary supplement manufacturing, having scored a perfect 100% on its most recent cGMP dietary supplements audit performed by Eurofins, the world leader in food and pharmaceutical testing. Treehouse Biotech holds a portfolio of patents and patent applications covering the extraction and synthesis of various cannabinoids, including US Patent No. 10,239,808 which covers the removal of tetrahydrocannabinol, or THC, from hemp extracts via chromatography.

About Next Frontier Brands
Next Frontier Brands is an international fast-moving consumer goods company dedicated to bringing premier beverage and wellness products to consumers globally. We own 15 beverage and wellness brands which are distributed globally, and we are actively acquiring new brands. Our beverage brands include products in the distilled alcoholic spirits, distilled non-alcoholic spirits, wine, and coffee categories, and our wellness brands include products in the concentrate, topical and sublingual categories. We are headquartered in Boulder, Colorado, with additional offices in London, England, Amsterdam, The Netherlands, and Auckland, New Zealand.

Logo - https://mma.prnewswire.com/media/1312933/Next_Frontier_Brands_Logo.jpg

© 2021 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.